Showing results (291-300 of 301) with videos related to

Sort By:
Pageof 31
Pediatric Research|December 3, 2025
Congenital and infantile nephrotic syndrome: genotype-phenotype associationsMd Saimul Islam, Alexandru R Constantinescu, William E Smoyer, et al.
Tropical Medicine and Health|March 29, 2025
Geospatial analysis of cholera outbreak in Lusaka, Zambia, between 2023 and 2024William Ngosa, Tadatsugu Imamura, Nyuma Mbewe, et al.
Open Forum Infectious Diseases|April 30, 2025
Clinical Characteristics and Factors Associated With Severe Outcomes of 1891 Pediatric Patients Admitted to the Referral Cholera Treatment Centers in Lusaka, Zambia, December 2023-March 2024Nawa Kalima, Tadatsugu Imamura, Ilunga Chambah, et al.
Scientific Reports|July 11, 2025
Defining subgroups of pediatric nephrotic patients with urine proteomicsTimothy D Cummins, Laura H Mariani, Daniel W Wilkey, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Case of Invasive Ductal Carcinoma in the Fat Replacement of the Pancreatic Body and Tail]Takeshi Ebihara, Tameyoshi Yamamoto, Hiromitsu Hoshino, et al.
Breast Cancer Research and Treatment|October 15, 2013
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapyS Ohno, L W C Chow, N Sato, et al.
Frontiers in Pediatrics|October 10, 2022
Clinical presentation and management of nephrotic syndrome in the first year of life: A report from the Pediatric Nephrology Research ConsortiumAlexandru R Constantinescu, Tej K Mattoo, William E Smoyer, et al.
Open Forum Infectious Diseases|June 4, 2025
Clinical Characteristics of 6578 Adult Patients With Cholera Admitted to Community and Referral Cholera Treatment Centers in Lusaka, Zambia, October 2023 to April 2024Nyuma Mbewe, Tadatsugu Imamura, Suilanji Sivile, et al.
Emerging Infectious Diseases|July 23, 2024
Fatal SARS-CoV-2 Infection among Children, Japan, January-September 20221Shingo Mitsushima, Yuichiro Yahata, Yuuki Tsuchihashi, et al.
Translational Oncology|July 24, 2024
TP53 signature predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: Observational and confirmational study using prospective study cohortsShin Takahashi, Nobuaki Sato, Kouji Kaneko, et al.
Pageof 31